The use of Lactobacillus plantarum 299v (DSM 9843) in cancer patients receiving home enteral nutrition - study protocol for a randomized, double-blind, and placebo-controlled trial

Karolina Kaźmierczak-Siedlecka, Marcin Folwarski, Karolina Skonieczna-Żydecka, Jakub Ruszkowski, Wojciech Makarewicz, Karolina Kaźmierczak-Siedlecka, Marcin Folwarski, Karolina Skonieczna-Żydecka, Jakub Ruszkowski, Wojciech Makarewicz

Abstract

Background: Nutritional treatment is one of the most important components of multidisciplinary anti-cancer therapy. Home enteral nutrition is considered as a safe procedure, however, it may be associated with the risk of side effects, such as nausea, vomiting, abdominal pain, and diarrhoea. It is uncertain whether diarrhoea is the result of the enteral formula administration or gut dysbiosis. One of the methods which may be used to alter the composition of gut microbiota is the administration of a probiotic strain. Lactobacillus plantarum 299v ingestion was found to diminish the adverse events of irritable bowel syndrome and Clostridium difficile infection - entities that share the symptoms with enteral nutrition side effects. Therefore, the primary aim of this study is to determine the effect of Lactobacillus plantarum 299v on prevention of weight loss of cancer patients receiving home enteral nutrition. The secondary aims are to evaluate the role of this probiotic strain in the improvement of nutritional status, enteral nutrition tolerance, and patients' quality of life.

Methods: Forty patients with cancer receiving home enteral nutrition will be enrolled in this clinical trial and randomized to receive one capsule of Lactobacillus plantarum 299v (Sanprobi IBS®) twice a day or placebo for 12 weeks in a double-blind manner. Laboratory tests (the level of albumin, total protein, transferrin, and total lymphocyte count), anthropometric parameters (body mass, the content of fat mass, muscle mass, and total body water), Nutritional Risk Screening (NRS 2002), enteral nutrition tolerance as well as quality of life will be measured. Measurements will be obtained at the baseline and after 4 and 12 weeks of treatment.

Discussion: The adverse events observed during administration of enteral nutrition have an negative impact on enteral formula tolerance and as a consequence patients' quality of life. The previous studies have demonstrated that probiotics may reduce the gastrointestinal symptoms related to enteral nutrition. Thus, administration of Lactobacillus plantarum 299v may be effective in improvement of nutritional status, enteral nutrition tolerance, and quality of life of cancer patients receiving home enteral nutrition.

Trial registration: ClinicalTrials.gov Identifier: NCT03940768 .

Keywords: Cancer; Home enteral nutrition; Lactobacillus plantarum 299v; Nutritional status.

Conflict of interest statement

The company Sanprobi IBS® provided probiotics and placebo. They did not participate in study design or writing this study protocol. KSŻ received remuneration from Sanprobi; however, it has no relation with this article.

Figures

Fig. 1
Fig. 1
Participants flow diagram

References

    1. Gavazzi C, Colatruglio S, Valoriani F, Mazzaferro V, Sabbatini A, Biffi R, et al. Impact of home enteral nutrition in malnourished patients with upper gastrointestinal cancer: a multicentre randomised clinical trial. Eur J Cancer. 2016;64:107–112. doi: 10.1016/j.ejca.2016.05.032.
    1. Gramlich L, Hurt RT, Jin J, Mundi MS. Home enteral nutrition: towards a standard of care. Nutrients. 2018;8:1020. doi: 10.3390/nu10081020.
    1. Villar Taibo R, Martínez Olmos MÁ, Bellido Guerrero D, Casariego AV, Garcia RP, Sueiro AM, et al. Epidemiology of home enteral nutrition: an approximation to reality. Nutr Hosp. 2018;3:511–518.
    1. Dohonoe CL, Ryan AM, Reynolds JV. Cancer cachexia: mechanisms and clinical implications. Gastroenterol Res Pract. 2011;601434. 10.1155/2011/601434.
    1. Aoyagi T, Terracina KP, Raza A, Matsubara H, Takabe K, et al. Cancer cachexia, mechanism and treatment. World J Gastroenterol Oncol. 2015;4:17–25. doi: 10.4251/wjgo.v7.i4.17.
    1. Whelan K. Enteral-tube-feeding diarrhoea: manipulating the colonic microbiota with probiotics and prebiotics. Proc Nutr Soc. 2007;3:299–306. doi: 10.1017/S0029665107005551.
    1. D’Argenio V, Salvatore F. The role of the gut microbiome in the healthy adult status. Clin Chim Acta. 2015;451:97–102. doi: 10.1016/j.cca.2015.01.003.
    1. Banna GL, Torino F, Marletta F, Santagati M, Salemi R, Cannarozzo E, et al. Lactobacillus rhamnosus GG: an overview to explore the rationale of its use in Cancer. Front Pharmacol. 2017;8:603. doi: 10.3389/fphar.2017.00603.
    1. Raman M, Ambalam P, Kondepudi K, Pithva S, Kothari C, Patel A, et al. Potential of probiotics, prebiotics and synbiotics for management of colorectal cancer. Gut Microbes. 2013;3:181–192. doi: 10.4161/gmic.23919.
    1. Chen D, Wu J, Jin D, Wang B, Cao H. Fecal microbiota transplantation in Cancer management: current status and perspectives. Int J Cancer. 2019;8:2021–2031. doi: 10.1002/ijc.32003.
    1. Johansson ML, Molin G, Jeppsson B, Nobaek S, Ahrné S, Bengmark S. Administration of different Lactobacillus strains in fermented oatmeal soup: in vivo colonization of human intestinal mucosa and effect on the indigenous flora. Appl Environ Microbiol. 1993;59:15–20. doi: 10.1128/AEM.59.1.15-20.1993.
    1. Kaźmierczak-Siedlecka K, Daca A, Folwarski M, Witkowski J, Bryl E, Makarewicz W. The role of Lactobacillus plantarum 299v in supporting treatment of selected diseases. Cent Eur J Immunol. (accepted).
    1. Mack DR, Ahrne S, Hyde L, Wei S, Hollingsworth MA. Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut. 2003;6:827–833. doi: 10.1136/gut.52.6.827.
    1. Niedzielin K, Kordecki H, Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2001;13:1143–1147. doi: 10.1097/00042737-200110000-00004.
    1. Cederholm T, Jensen GL, Correia MITD, Gonzalez MC, Fukushima R, Higashiguchi T, et al. GLIM criteria for the diagnosis of malnutrition – a consensus report from the global clinical nutrition community. J Cachexia Sarcopenia Muscle. 2019;1:207–217. doi: 10.1002/jcsm.12383.
    1. Marlicz W, Zawada I, Starzyńska T. Irritable bowel syndrome--irritable bowel or irritable mind? Pol Merkur Lek Organ Pol Tow Lek. 2012;32:64–69.
    1. Hoppe M, Önning G, Hulthén L. Freeze-dried Lactobacillus plantarum 299v increases iron absorption in young females—double isotope sequential single-blind studies in menstruating women. PLoS One. 2017;12:e0189141. doi: 10.1371/journal.pone.0189141.
    1. Dudzicz S, Kujawa-Szewieczek A, Kwiecień K, Więcek A, Adamczak M. Lactobacillus plantarum 299v reduces the incidence of Clostridium difficile infection in nephrology and transplantation ward-results of one year extended study. Nutrients. 2018;10:1574. doi: 10.3390/nu10111574.
    1. Wullt M, Johansson Hagslätt M, Odenholt I. Lactobacillus Plantarum 299v for the treatment of recurrent clostridium Difficile-associated Diarrhoea: a double-blind. Placebo-Controlled Trial Scand J Infect Dis. 2003;6-7:365–367. doi: 10.1080/00365540310010985.
    1. Lönnermark E, Friman V, Lappas G, Sandberg T, Berggren A, Adlerberth I. Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics. J Clin Gastroenterol. 2010;2:106–112. doi: 10.1097/MCG.0b013e3181b2683f.
    1. Zaman MK, Chin K, Rai V, Majid HA. Fiber and prebiotic supplementation in enteral nutrition: a systematic review and meta-analysis. World J Gastroenterol. 2015;17:5372–5381. doi: 10.3748/wjg.v21.i17.5372.
    1. Wiesen P, Van Gossum A, Preiser JC. Diarrhoea in the critically ill. Curr Opin Crit Care. 2006;12:149–154. doi: 10.1097/01.ccx.0000216583.64804.46.
    1. Zhao R, Wang Y, Huang Y, Cui Y, Xia L, Rao Z, et al. Effects of fiber and probiotics on diarrhea associated with enteral nutrition in gastric cancer patients. Medicine. 2017;96:e8418. doi: 10.1097/MD.0000000000008418.
    1. Xie H, Lu Q, Wang H, Zhu X, Guan Z. Effects of probiotics combined with enteral nutrition on immune function and inflammatory response in postoperative patients with gastric cancer. J Buon. 2018;23:678–683.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera